Flow cell

By using the flow cell of cationic polymer hydrogel in DNA sequencing technology, the introduction of positive charge attraction and restriction of library fragments is solved, and the quality and analysis efficiency of sequencing results are improved.

CN113302311BInactive Publication Date: 2024-11-08ILLUMINA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080007599.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-08-01
Filing Date
2020-07-22
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the existing DNA sequencing technology, it is difficult to effectively attract and limit library fragments during DNA fragmentation and labeling, resulting in low inoculation efficiency and affecting the quality of sequencing results and analysis efficiency.

Method used

Using a flow cell including cationic polymer hydrogel, the inoculation efficiency is improved by introducing positive charges on the surface of the polymer hydrogel, attracting and limiting negatively charged library fragments, reducing random binding and sidewall inoculation.

Benefits of technology

It improves the inoculation efficiency of library fragments, reduces crosstalk and overlap of spatial clouds, and improves the recognition of sequencing results and data quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113302311B_ABST
    Figure CN113302311B_ABST
Patent Text Reader

Abstract

An example of a flow cell includes a substrate and a cationic polymer hydrogel on the substrate. The cationic polymer hydrogel includes a cationic moiety that is i) integrated into a monomer unit of an initial polymer hydrogel, or ii) attached to the monomer unit of the initial polymer hydrogel via a linker. The flow cell also includes an amplification primer attached to the cationic polymer hydrogel.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Cross-references to related patent applications

[0002] This application claims the benefit of U.S. Provisional Application Serial No. 62 / 881,597, filed on August 1, 2019; the contents of which are incorporated herein by reference in their entirety. Background Art

[0003] There is a variety of methods and applications for libraries of fragmented and labeled deoxyribonucleic acid (DNA) molecules that wish to be produced by double-stranded DNA (dsDNA) target molecules. Generally, the purpose is to generate smaller DNA molecules (e.g., DNA fragments) by larger dsDNA molecules to be used as templates in DNA sequencing reactions. These templates can make it possible to obtain short read lengths. In the data analysis process, overlapping short sequence reads can be compared to rebuild longer nucleic acid sequences. In some cases, a pre-sequencing step (such as barcoding specific nucleic acid molecules) can be used to simplify data analysis. Summary of the invention

[0004] The first aspect disclosed herein is a flow cell comprising a substrate; a cationic polymer hydrogel on the substrate, the cationic polymer hydrogel comprising a cationic portion, which cationic portion i) is integrated into a monomer unit of an initial polymer hydrogel, or ii) is attached to a monomer unit of the initial polymer hydrogel through a linker; and an amplification primer attached to the cationic polymer hydrogel.

[0005] In one example of the first aspect, the monomer unit is N-(5-bromoacetamidopentyl)acrylamide; the cationic moiety is a phosphonium cation; and the phosphonium cation replaces the bromine of N-(5-bromoacetamidopentyl)acrylamide. In one example, the phosphonium cation is selected from the group consisting of tris(hydroxymethyl)phosphonium cation, tris(hydroxypropyl)phosphonium cation, tetrakis(hydroxymethyl)phosphonium cation, and tris(2-carboxyethyl)phosphonium cation.

[0006] In another example of the first aspect, i) the monomer unit includes a terminal azide group and the linker includes an alkyne group; or ii) the monomer unit includes a terminal alkyne group and the linker includes an azide group. In one example, the cationic moiety includes a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof. In another example, the monomer unit is N-(5-azidoacetamidopentyl)acrylamide; and the cationic moiety is an N,N,N-trimethylethanolammonium cation. In yet another example, the linker also includes a cleavable disulfide bond, a photolyzable bond, a cleavable phosphodiester bond, or a combination thereof.

[0007] In yet another example of the first aspect, the monomer unit is N-(5-azidoacetamidopentyl)acrylamide; the linker includes a terminal alkyne group and a terminal bromine; and the cationic moiety is a phosphonium cation replacing the terminal bromine.

[0008] In one example of the first aspect, the substrate includes a plurality of recessed portions separated by void areas, and wherein the cationic polymer hydrogel is located within each of the recessed portions. In one example, the substrate further includes a plurality of chambers, and wherein a subset of the plurality of recessed portions is located within the perimeter of each of the plurality of chambers.

[0009] It should be understood that any of the features of the flow cells disclosed herein can be combined together in any desired manner and / or configuration to achieve the benefits as described in the present disclosure, including, for example, achieving positive charges to attract and spatially confine library fragments.

[0010] The second aspect disclosed herein is a method comprising: introducing a fluid comprising a positively chargeable portion into a flow cell, the flow cell comprising an initial polymer hydrogel having a surface portion selected from the group consisting of a negatively chargeable atom, an azide group, and an alkyne group; and an amplification primer attached to the initial polymer hydrogel; and incubating the initial polymer hydrogel in the fluid at a certain temperature for a period of time to form a cationic polymer hydrogel comprising a cationic portion.

[0011] In one example of the second aspect, the positively chargeable moiety replaces the negatively chargeable atoms of the initial polymer hydrogel. In one example, the surface moiety is a negatively chargeable atom; the negatively chargeable atom is bromine; and the positively chargeable moiety is selected from the group consisting of: tris(hydroxymethyl)phosphine, tris(hydroxypropyl)phosphine, tetrakis(hydroxymethyl)phosphine, and tris(2-carboxyethyl)phosphine. In one example, the fluid also includes a buffer having a pH in the range of 6 to 12. In one example, the temperature is in the range of about 18°C ​​to about 65°C, and the time is in the range of about 1.5 minutes to about 5 minutes.

[0012] In another example of the second aspect, the surface portion is an azide group or an alkyne group; and the positively charged portion is covalently attached to the surface portion by a linker. In one example, the surface portion is an azide group; the linker is an alkyne group; and the cationic portion includes a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof. In one example, the surface portion is an alkyne group; the linker is an azide group; and the cationic portion includes a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof. In one example, the compound includes a positively charged portion attached to a linker, and wherein the compound is propargyl choline bromide. In one example, the fluid includes water. In one example, the temperature is in the range of about 18°C ​​to about 60°C, and the time is in the range of about 30 minutes to about 12 hours. In one example, the method also includes adding a catalyst, a ligand, and a reducing agent to the circulation pool together with the fluid.

[0013] It should be understood that any features of the method can be combined in any desired manner. In addition, it should be understood that any combination of features of the method and / or flow cell can be used together, and / or combined with any examples disclosed herein to achieve benefits as described in the present disclosure, including, for example, achieving positive charges to attract and spatially restrict library fragments.

[0014] A third aspect disclosed herein is a kit comprising a flow cell comprising a substrate; an initial polymer hydrogel located on the substrate and having a surface portion selected from the group consisting of negatively chargeable atoms, azide groups, and alkyne groups; and an amplification primer attached to the initial polymer hydrogel; and a fluid comprising a positively chargeable portion that will interact or react with the surface portion to form a cationic polymer hydrogel comprising a cationic portion.

[0015] It should be understood that any features of the kit can be combined in any desired manner. In addition, it should be understood that any combination of features of any of the kit and / or method and / or flow cell can be used together, and / or combined with any examples disclosed herein to achieve benefits as described in the present disclosure, including, for example, achieving positive charges to attract and spatially restrict library fragments. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] By referring to the following detailed description and accompanying drawings, the features of the examples of the present disclosure will become apparent, wherein like reference numerals correspond to similar but possibly not identical parts. For the sake of brevity, reference numerals or features having previously described functions may or may not be described in conjunction with other drawings in which they appear.

[0017] Figure 1 is a flow chart illustrating an example of a method disclosed herein;

[0018] Figure 2A and Figure 2B is shown together Figure 1 A semi-schematic perspective view of a method of Figure 2A A portion of a flow cell including an initial polymer hydrogel is shown, and Figure 2B A portion of a flow cell comprising a positively charged (cationic) polymer hydrogel is shown;

[0019] Figure 3 is a chemical formula showing the formation of one example of a cationic polymer hydrogel;

[0020] Figure 4 is a chemical formula showing the formation of another example of a cationic polymer hydrogel;

[0021] Figure 5A and Figure 5B Depicted together are chemical formulas showing the formation of yet another example of a cationic polymer hydrogel;

[0022] Figure 6 is a semi-schematic perspective view of a portion of another example of a flow cell disclosed herein;

[0023] Figure 7 is a semi-schematic perspective view of a portion of yet another example of a flow cell disclosed herein; and

[0024] FIG. 8A to FIG. 8C are schematic diagrams of various examples of complexes disclosed herein;

[0025] Fig. 9A is an inverted microscopic image (wherein the original dark portion of the image has been inverted to white, and the original light portion of the image has been inverted to black) of released DNA library fragments on a comparison flow cell comprising an untreated hydrogel in a single channel of a glass substrate;

[0026] Fig. 9B yes Fig. 9A Schematic diagram comparing the interaction of released DNA library fragments from the flow cell with untreated hydrogel;

[0027] Fig. 10A is an inverted microscopic image of released DNA library fragments on an embodiment flow cell (wherein the originally dark portion of the image has been inverted to white, and the originally light portion of the image has been inverted to black), the embodiment flow cell comprising a hydrogel treated with tris(hydroxypropyl)-phosphine in a single channel of a glass substrate; and

[0028] Fig. 10B yes Fig. 10AExample of a flow cell. Schematic representation of the interaction of the released DNA library fragments and the treated hydrogel. DETAILED DESCRIPTION

[0029] Examples of flow cells disclosed herein include positive charges at the surface of the polymer hydrogel and amplification primers. The positive charges at the surface of the polymer hydrogel help to attract and spatially confine library fragments released from carriers that are subsequently introduced into the flow cell.

[0030] The library fragments are single-stranded, similar-sized (e.g., <1000 bp) deoxyribonucleic acid (DNA) pieces of a larger nucleic acid sample or complementary deoxyribonucleic acid (cDNA) pieces produced by ribonucleic acid (RNA) pieces of a larger nucleic acid sample, and the two ends of these fragments have joints. The positively charged hydrogel surface will attract negatively charged library fragments released from a single carrier. This will reduce the random binding of library fragments on the entire flow cell surface, and will reduce or prevent the library fragments from being seeded on the side walls of the flow cell. Therefore, the library seeding efficiency is improved.

[0031] Improved seeding efficiency can have many advantages and benefits. For example, when seeding efficiency is improved, library input requirements can be reduced. As another example, improved seeding efficiency can produce at least substantially uniform cluster density. During sequencing, when nucleotides are incorporated into the corresponding template strands of the cluster, each cluster produces a "spatial cloud" of fluorescent signals. The restriction of clusters can at least reduce spatial cloud crosstalk and / or overlap, and can also improve the identification of spatial clouds. In addition, because the reads obtained from any single cluster can be generated by the same sample, they can be used to reconstruct the sample by splicing short reads together in a bioinformatic manner.

[0032] Examples of the methods disclosed herein introduce positive charges to the surface of an initial polymer hydrogel while maintaining sequencing compatibility of the surface.

[0033] definition

[0034] Unless otherwise indicated, the terms used herein should be understood to have their ordinary meanings in the relevant art. Several terms used herein and their meanings are listed below.

[0035] As used herein, the singular forms "a", "an", and "the" include both the singular and the plural, unless the context clearly dictates otherwise. As used herein, the term "comprising" is synonymous with "including", "containing", or "characterized by", is inclusive or open-ended, and does not exclude additional unrecited elements or method steps.

[0036] The references to "one example", "another example", "example", etc. throughout this specification mean that the specific elements (e.g., features, structures, compositions, configurations, and / or characteristics) described in conjunction with the example are included in at least one example described herein and may or may not be present in other examples. In addition, it should be understood that the elements used in any example may be combined in any suitable manner in the various examples unless the context clearly indicates otherwise.

[0037] The terms "substantially" and "approximately" used throughout this disclosure (including claims) are used to describe and illustrate small fluctuations, such as those caused by changes in processing. For example, these terms can refer to less than or equal to ±5% of a specified value, such as less than or equal to ±2% of a specified value, such as less than or equal to ±1% of a specified value, such as less than or equal to ±0.5% of a specified value, such as less than or equal to ±0.2% of a specified value, such as less than or equal to ±0.1% of a specified value, such as less than or equal to ±0.05% of a specified value.

[0038] Joint: A linear oligonucleotide sequence that can be fused to a nucleic acid molecule, for example, by connection or labeling. In some examples, the joint is not substantially complementary to the 3' end or 5' end of any target sequence introduced into the flow cell. Suitable joint lengths can be in the range of about 10 nucleotides to about 100 nucleotides or about 12 nucleotides to about 60 nucleotides or about 15 nucleotides to about 50 nucleotides. The joint may include any combination of nucleotides and / or nucleic acids. In some examples, the joint includes one or more cleavable groups at one or more positions. In some examples, the joint may include a sequence complementary to at least a portion of a primer (e.g., a primer including a universal nucleotide sequence (such as a P5 or P7 sequence)). In some examples, the joint may include an index or barcode sequence that contributes to downstream error correction, identification or sequencing. The index may be unique to a sample or source of a nucleic acid molecule (e.g., a fragment). In some examples, the joint may include a sequencing primer sequence or a sequencing binding site. Combinations of different joints may be incorporated into nucleic acid molecules (such as DNA fragments).

[0039] Capture site: A portion of a flow cell surface that has been modified physically and / or with chemical properties that allow for localization of a complex or sample. In one example, a capture site may include a chemical capture agent.

[0040] Support: A hydrogel support that can have a sequencing library contained therein, or a solid support that can have attached to its surface ready-to-sequence nucleic acid fragments.

[0041] Chemical capture agent: a material, molecule or part capable of attaching, retaining or binding to a target molecule (e.g., a complex or sample). An exemplary chemical capture agent includes a capture nucleic acid (e.g., a capture oligonucleotide) that is complementary to at least a portion of the target nucleic acid of the target molecule or attached to the target molecule. Another exemplary chemical capture agent is a linker molecule. For natural DNA or RNA samples, the linker molecule may include a nucleic acid binding portion on one end, such as an intercalator bound via charge or hydrophobic interactions. For cell samples, the linker molecule may include a cell membrane binding portion (e.g., an antigen against a surface protein) or a membrane penetrating portion (e.g., a phospholipid on one end). Yet another exemplary chemical capture agent includes a member of a receptor-ligand binding pair (e.g., avidin, streptavidin, biotin, lectin, carbohydrate, nucleic acid binding protein, epitope, antibody, etc.) capable of binding to a target molecule (or binding to a linker attached to a target molecule). Yet another example of a chemical capture agent is a chemical reagent that is capable of forming electrostatic interactions, hydrogen bonds, or covalent bonds (eg, thiol-disulfide exchange, click chemistry, Diels-Alder, etc.) with a target molecule.

[0042] Complex: A support, such as a hydrogel support or a solid support, and a ready-to-sequence nucleic acid fragment attached to or contained within the support. The support may also include one member of a binding pair, the other member of which is part of a capture site.

[0043] External fixative: A gas, liquid, or viscous medium that is immiscible with the complex or sample that has been introduced into the flow cell channel or chamber. A gaseous external fixative can be used to generate droplets around the complex or sample. An example of a gaseous external fixative is air that is directed through the flow cell at a suitable flow rate. For example, air can be used to draw a fluid containing the complex or sample from the flow cell, which forms droplets of the liquid containing the complex or sample. The droplets formed serve as a diffusion barrier. The liquid or viscous medium is used to prevent the diffusion of the sequencing library released from the complex or formed in the chamber on the surface of the flow cell. The external fixative can form a diffusion barrier because the sequencing library or any other polynucleotide is barely solvated in the external fixative. Exemplary external fixatives in liquid form include hydrophobic oils such as mineral oil, silicone oil, perfluorinated oil, fluorinated carbon oil (e.g., FLUORINERT from 3M). TMElectronic Liquid FC40) or a combination thereof. Exemplary external fixatives in the form of viscous media include buffers containing polymers (e.g., polyethylene glycol, polyvinyl pyrrolidone, etc.), dextran, sucrose, glycerol, etc. In some examples, the viscous medium is a temperature-responsive gel. The temperature-responsive gel is non-viscous at a non-seeding temperature and becomes a viscous medium at an inoculation temperature. Examples of temperature-responsive gels include poly (N-isopropylacrylamide) and polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO) / synthetic hectorite nanoparticle complexes.

[0044] Fragment: A portion or piece of genetic material (eg, DNA, RNA, etc.).

[0045] Hydrogel or hydrogel matrix: a semi-rigid polymer material that is permeable to liquids and gases. The polymer material forming the hydrogel can be linear or lightly cross-linked via covalent bonds, ionic bonds, or hydrogen bonds. In one example, the hydrogel includes about 60% to about 90% of a fluid (such as water) and about 10% to about 30% of a polymer. The hydrogel can be porous, i.e., including open / void spaces. Porosity is the fractional volume (dimensionless) of the hydrogel, i.e., the void space in the measurement material, which is the fraction of the void volume to the total volume, expressed as a percentage between 0 and 100% (or a fraction between 0 and 1). In one example, the porosity of the hydrogel can be in the range of about 50% (0.5) to about 99% (0.99). The porosity can be sufficient to allow reagents (e.g., enzymes, chemicals, and smaller oligonucleotides (less than 50 base pairs, such as primers)) to diffuse, but prevent larger nucleic acid molecules (e.g., samples, fragments, etc.) from diffusing.

[0046] The term "cationic polymer hydrogel" as used herein refers to an initially polymerized hydrogel having a cationic moiety that is i) integrated into one of the monomer units or ii) attached to one of the monomer units via a linker. The term "initial polymer hydrogel" as used herein refers to a polymerized hydrogel prior to any reaction / interaction that introduces the cationic moiety. Cationic polymer hydrogels may also be referred to herein as positively charged hydrogels.

[0047] Hydrogel support: A hydrogel having an at least substantially spherical shape (eg, a hydrogel bead) that can contain a sequencing library therein.

[0048] Nucleic acid molecule: A polymeric form of nucleotides of any length and may include ribonucleotides, deoxyribonucleotides, their analogs, or mixtures thereof. The term may refer to a single-stranded or double-stranded polynucleotide.

[0049] A "target" or "template" nucleic acid molecule may refer to the sequence to be analyzed.

[0050] Nucleotides in nucleic acid molecules can include naturally occurring nucleic acids and functional analogs thereof. Examples of functional analogs can hybridize with nucleic acids in a sequence-specific manner or can be used as templates for replicating specific nucleotide sequences. Naturally occurring nucleotides typically have a backbone containing a phosphodiester bond. Similar structures can have alternative backbone bonds, including any of a variety of backbone bonds known in the art. Naturally occurring nucleotides typically have deoxyribose (e.g., present in DNA) or ribose (e.g., present in RNA). Similar structures can have alternative sugar moieties, including any of a variety of sugar moieties known in the art. Nucleotides can include natural or non-natural bases. Natural DNA can include one or more of adenine, thymine, cytosine and / or guanine, and natural RNA can include one or more of adenine, uracil, cytosine and / or guanine. Any non-natural bases can be used, such as locked nucleic acids (LNA) and bridge nucleic acids (BNA).

[0051] Positively chargeable moiety: A positively chargeable moiety can be any functional group that carries or can carry a positive charge. In one example, a positive charge can be introduced into a chargeable moiety by a displacement reaction. In other examples, a positively chargeable moiety carries a positive charge at a specific pH (e.g., physiological pH).

[0052] Primer: A nucleic acid molecule that can hybridize with a target sequence of interest. In one example, a primer is used as a substrate to which nucleotides can be polymerized by a polymerase. For example, an amplification or capture primer can be used as a starting point for template amplification and cluster generation. In another example, a synthetic nucleic acid chain may include a site to which a primer (e.g., a sequencing primer) can hybridize to initiate the synthesis of a new chain complementary to the synthetic nucleic acid chain. Any primer may include any combination of nucleotides or their analogs. In some examples, a primer is a single-stranded oligonucleotide or polynucleotide. The primer length can be any number of bases long, and may include a variety of non-natural nucleotides. In one example, a sequencing primer is a short chain ranging from 10 to 60 bases, or 20 to 40 bases.

[0053] Sample: Any source of genetic material, such as a cell, a microbial population, or a nucleic acid. In some examples, the cell is a single cell, including a prokaryotic cell or a eukaryotic cell. In some examples, the cell is a mammalian cell, a human cell, or a bacterial cell. In some examples, the nucleic acid is a long DNA molecule, including a viral nucleic acid, a bacterial nucleic acid, or a mammalian nucleic acid. In some examples, the sample is bound (as a fragment) via insertion into a transposon bound to the surface of a solid support (e.g., a bead).

[0054] Ready-to-sequencing nucleic acid fragments: A portion (fragment) of the genetic material having adapters at the 3' and 5' ends. In the ready-to-sequencing nucleic acid fragments, each adapter includes a known universal sequence (e.g., which is complementary to at least a portion of the primers on the circulation pool) and a sequencing primer sequence. The two adapters may also include an index (barcode or label) sequence. In one example, one side (e.g., the P5 side) may contain a bead (or other solid support) index, and the other side (e.g., the P7 side) may contain a sample index. Ready-to-sequencing nucleic acid fragments can be bound to the surface of a solid support (e.g., a bead) via insertion of a transposon, or directly fixed by a binding pair or other cleavable linker. Ready-to-sequencing nucleic acid fragments may also be contained within a hydrogel support.

[0055] Seeding: Adapter fragments (eg, nucleic acid fragments to be sequenced) are immobilized on a hydrogel of an example flow cell disclosed herein.

[0056] Sequencing library: A collection of nucleic acid fragments of one or more target nucleic acid molecules, or amplicons of these fragments. In some examples, the fragments are connected to one or more adapters at their 3' and 5' ends. In some examples, a sequencing library is prepared from one or more target nucleic acid molecules and is part of a complex.

[0057] Solid support: A small body made of a rigid or semi-rigid material, whose shape can be characterized, for example, by spherical, ellipsoidal, microspherical, or other recognized particle shapes, whether of regular or irregular size. The solid support can have a sequencing library attached to it. Exemplary materials that can be used for solid supports include, but are not limited to, glass; plastics such as acrylic, polystyrene or a copolymer of styrene and another material, polypropylene, polyethylene, polybutylene, polyurethane, or polytetrafluoroethylene (available from The Chemours Co. ); polysaccharides or cross-linked polysaccharides, such as agarose or agarose gel; nylon; nitrocellulose; resins; silica or silica-based materials, including silicon and modified silicon; carbon fibers, metals; inorganic glass; fiber optic bundles, or a variety of other polymers. Exemplary solid supports include controlled pore glass beads, paramagnetic beads, thoria sols, agarose gel beads, nanocrystals, and other solid supports known in the art, such as, for example, described in the Microsphere Detection Guide from Bangs Laboratories, Fishers Ind.

[0058] Labeling: Modification of nucleic acid molecules (e.g., DNA or RNA samples) by transposomes to fragment the nucleic acid molecules and attach adapters to the 5' and 3' ends of the fragments in a single step. The labeling reaction can be used to prepare sequencing libraries, especially complexes that include solid supports. The labeling reaction combines random sample fragmentation and adapter ligation into a single step, which improves the efficiency of the sequencing library preparation process.

[0059] Transposome: An integration enzyme (eg, an integrase or a transposase) and a nucleic acid comprising an integration recognition site (eg, a transposase recognition site).

[0060] Universal nucleotide sequence: A sequence region common to two or more nucleic acid molecules, where these molecules also have regions that differ from each other. Universal sequences present in different members of a collection of molecules can allow the capture of several different nucleic acids using a population of universal capture nucleic acids (i.e., linkers having a sequence that is complementary to at least a portion of a primer). Similarly, universal sequences present in different members of a collection of molecules can allow the amplification or replication of several different nucleic acids using a population of universal sequencing binding sites (sequencing primer sequences).

[0061] Method for preparing positively charged flow cell surface

[0062] An example of an example method 100 for forming a flow cell is Figure 1 As depicted, one example of method 100 includes: introducing a fluid including a positively chargeable portion into a flow cell, the flow cell including an initial polymer hydrogel having a surface portion selected from the group consisting of a negatively chargeable atom, an azide group, and an alkyne group, and an amplification primer (reference numeral 102) attached to the initial polymer hydrogel; and incubating the initial polymer hydrogel in the fluid for a period of time at a certain temperature to form a cationic polymer hydrogel including a cationic portion (reference numeral 104).

[0063] Method 100 is still available Figure 2A and Figure 2B It is schematically shown in FIG.

[0064] like Figure 2A As shown, at the beginning of method 100, the flow cell 10 P (It is Figure 2B The flow cell 10 (precursor) shown includes a substrate 12, an initial polymer hydrogel 14' on the substrate 12, and an amplification primer 18 attached to the initial polymer hydrogel 14'.

[0065] The substrate 12 is generally rigid and insoluble in aqueous liquids. Examples of suitable substrates 12 include epoxysiloxane, polyhedral oligomeric silsesquioxane (POSS) or derivatives thereof, glass, modified glass, plastic, nylon, ceramic / ceramic oxides, silicon dioxide (silicon oxide (SiO2)), fused silica, silicon dioxide-based materials, aluminum silicate, silicon, modified silicon (e.g., p+ silicon doped with boron), silicon nitride (Si3N4), tantalum pentoxide (TaO5) or other tantalum oxides (TaO x ), hafnium oxide (HfO2), inorganic glass, etc. An example of POSS may be the POSS described by Kehagias et al. in Microelectronic Engineering 86 (2009) pp. 776-778, which is incorporated by reference in its entirety. Some examples of plastics suitable for substrate 12 include acrylic resins, polystyrene, copolymers of styrene and other materials, polypropylene, polyethylene, polybutylene, polyurethane, polytetrafluoroethylene (such as available from The Chemours Co. ), cycloolefins / cycloolefin polymers (COP) (such as those available from Zeon ), polyimide, etc. The substrate 12 may also be glass or silicon or POSS with a coating of tantalum oxide or another ceramic oxide at the surface. Another example of a suitable substrate 12 is a silicon-on-insulator substrate.

[0066] The form of substrate 12 can be a wafer, panel, rectangular sheet, tube die or any other suitable configuration. In one example, substrate 12 can be a circular wafer or panel with a diameter in the range of about 2mm to about 300mm. As a more specific example, substrate 12 is a wafer with a diameter in the range of about 200mm to about 300mm. In another example, substrate 12 can be a rectangular sheet or panel with a maximum size of about 10 feet (about 3 meters) at most. As a specific example, substrate 12 is a tube die with a width in the range of about 0.1mm to about 10mm. Although exemplary dimensions have been provided, it should be understood that substrate 12 with any suitable size can be used.

[0067] Figure 2A The illustrated substrate 12 has a channel 20 defined therein. The channel 20 may be defined in the substrate 12 using any suitable technique that depends in part on the material of the substrate 12. In one example, the channel 20 is etched into a glass substrate 12. In another example, the channel 20 may be patterned into a resin substrate 12 using photolithography, nanoimprint lithography, or the like. In yet another example, a separate material (not shown) may be applied to the substrate 12 such that the separate material defines the walls of the channel 20 and the substrate 12 defines the bottom of the channel 20.

[0068] In one example, the channel 20 has a straight configuration. The length and width of the channel 20 may be less than the length and width of the substrate 12, respectively, so that the portion of the substrate surface 22 surrounding the channel 20 can be used for bonding to the cover (not shown). In some cases, the width of each channel 20 can be at least about 1mm, at least about 2.5mm, at least about 5mm, at least about 7mm, at least about 10mm or more. In some cases, the length of each channel 20 can be at least about 10mm, at least about 25mm, at least about 50mm, at least about 100mm or more. The width and / or length of each channel 20 can be greater than, less than, or between the values ​​specified above. In one example, the channel 20 is a square (e.g., 10mm×10mm).

[0069] When using microcontact, aerosol or inkjet printing to deposit a separate material defining the channel wall, the depth of each channel 20 can be a single layer thick. For other examples, the depth of each channel 20 can be about 1 μm, about 10 μm, about 50 μm or more. In one example, the depth can be in the range of about 10 μm to about 30 μm. In addition to attracting the positively charged polymer hydrogel of the released library fragment, the depth can also help block the lateral diffusion of the released library fragment between adjacent channels 20, for example, when using multiple channels 20. In another example, the depth is about 5 μm or less. It should be understood that the depth of each channel 20 is greater than, less than, or between the values ​​specified above.

[0070] Although Figure 2A A single channel 20 is shown in FIG. 1 , but it should be understood that the substrate 12 may include multiple channels (eg, 2, 3, 4, 8, etc.) that are fluidly separated from each other.

[0071] exist Figure 2A In the example shown, the channel 20 has an initial polymer hydrogel 14'. Figure 2B ) before, the hydrogel may be referred to as the initial polymer hydrogel 14' (see Figure 2A ). After the incorporation or attachment of the cationic moiety 16, the hydrogel may be referred to as a cationic polymer hydrogel 14 (see Figure 2B ).

[0072] The initial polymer hydrogel 14' may be a copolymer of at least two different monomer units. The initial polymer hydrogel 14' may be represented by: (M1) n (M2) m , wherein M1 is a first monomer unit, M2 is a second monomer unit, n is an integer in the range of 1 to 50,000, and m is an integer in the range of 1 to 100,000. In the cationic polymer hydrogel 14, M1 may be replaced by M1' (refer to Figure 3said) or M1" (reference Figure 4 The monomer units M1 and M2 are replaced with 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31,

[0073] One of the monomer units M1 includes a surface portion selected from the group consisting of an atom that can be charged negatively, an azide group, and an alkyne group. The atom that can be charged negatively can be any group that is easily displaced, such as a relatively weak nucleophilic substance. Some specific examples of atoms that can be charged negatively include halogens, such as bromine, iodine, etc.

[0074] Each of these surface portions of monomer unit M1 can be replaced by or covalently attached to amplification primer 18. For example, bromine can be replaced by a phosphorothioate group on the 5' end of primer 18. For another example, an azide group can be covalently attached to an alkyne group on the 5' end of primer 18. For another example, an alkyne group can be covalently attached to an azide group on the 5' end of primer 18.

[0075] Each of these surface portions of the monomer unit M1 may also enable the attachment of the cationic moiety 16 to the initial polymer hydrogel 14 ′ to generate the cationic polymer hydrogel 14 .

[0076] In some examples, a surface portion of monomer unit M1 is replaced by cationic portion 16, so that cationic portion 16 is integrated into monomer unit M1. In other words, cationic portion 16 is attached to monomer unit M1 at the same position where the surface portion was attached. For example, the surface portion can be a weaker redox species than cationic portion 16, and a replacement reaction can occur in which the surface portion is exchanged with cationic portion 16. An example of a replaceable surface portion is a negatively chargeable atom, such as bromine.

[0077] In other examples, the surface portion reacts with the linker to attach the cationic portion 16 to the monomer unit M1. For example, the azide group can be covalently linked to the terminal alkyne group of the linker. For another example, the alkyne group can be covalently linked to the terminal azide group of the linker.

[0078] Since the surface portions of monomer unit M1 are multifunctional, it is understood that some of the surface portions of monomer unit M1 will have amplification primer 18 attached, and some of the surface portions will be displaced by or attached to cationic moiety 16. In some cases, the amount of amplification primer 18 attached is about 10 times to about 50 times the amount of cationic moiety 16 attached.

[0079] Any monomer unit M1 including the surface moiety disclosed herein and copolymerizable with other monomer units M2 can be used to form the initial polymer hydrogel 14'. In one example, the monomer unit M1 (including the surface moiety) also includes an acrylamide unit: Variations of the acrylamide unit may also be used, for example, the carbon in the olefin may be optionally substituted or the N may be optionally substituted. Examples of other acrylamide units include methacrylamide, N,N-dimethylacrylamide, ethylacrylamide, and the like.

[0080] A specific example of a monomer unit M1 comprising both an acrylamide unit and bromine as the negatively chargeable atom is N-(5-bromoacetamidopentyl)acrylamide (brapa):

[0081]

[0082] Variations of N-(5-bromoacetamidopentyl)acrylamide may also be used, for example the alkyl chain -(CH2)- may range from 1 to 50, and / or each of the -(CH2)- may be optionally substituted.

[0083] A specific example of a monomer unit M1 comprising both an acrylamide unit and an azide group is N-(5-azidoacetamidopentyl)acrylamide:

[0084]

[0085] Variations of N-(5-azidoacetamidopentyl)acrylamide may also be used, for example, the alkyl chain -(CH2)- may range from 1 to 50, and / or each of -(CH2)- may be optionally substituted. Another example of a monomer unit M1 comprising both an acrylamide unit and an azide group is shown below:

[0086]

[0087] Wherein R1 is H or C1-C4 alkyl; R 2 is H or C1-C4 alkyl; L is a linking group including a straight chain having 2 to 20 atoms selected from the group consisting of carbon, oxygen and nitrogen and optional substituents on the carbon and any nitrogen atoms in the chain; E is a straight chain including 1 to 4 atoms selected from the group consisting of carbon, oxygen and nitrogen and optional substituents on the carbon and any nitrogen atoms in the chain; A is an N-substituted amide having H or C1-C4 alkyl attached to N; and Z is a nitrogen-containing heterocycle. Examples of Z include 5 to 10 ring members present as a single cyclic structure or a condensed structure. Yet another example of a monomer unit M1 including both an acrylamide unit and an azide group is represented as follows:

[0088]

[0089] Where R 3a R is selected from hydrogen, optionally substituted alkyl, optionally substituted phenyl or optionally substituted C7-C14 aralkyl; 3b is selected from hydrogen, optionally substituted alkyl or optionally substituted phenyl; and L 1 is selected from an optionally substituted alkylene linking group or an optionally substituted heteroalkylene linking group.

[0090] A specific example of a monomer unit M1 comprising both an acrylamide unit and an alkyne group is N-propargyl acrylamide:

[0091]

[0092] It is to be understood that other monomer units M1 can be used to form the initial polymer hydrogel 14', so long as they are functionalized with one of the surface moieties disclosed herein.

[0093] Any monomer unit M1 can be copolymerized with a second monomer unit M2 to form an initial polymer hydrogel 14'. Examples of the second monomer unit M2 include acrylamide units, N,N-dimethylacrylamide units:

[0094]

[0095] Where R 4a R is selected from hydrogen, optionally substituted alkyl, optionally substituted phenyl or optionally substituted C7-C14 aralkyl; 4b is selected from hydrogen, optionally substituted alkyl or optionally substituted phenyl; and L 2 is selected from an optionally substituted alkylene linking group or an optionally substituted heteroalkylene linking group. The second monomeric unit M2 does not include a surface portion of the first monomeric unit M1 (eg, a negatively chargeable atom, an azide group, or an alkyne group).

[0096] In other examples, monomer unit M1 can be copolymerized with both acrylamide units (e.g., monomer unit M2) and N,N-dimethylacrylamide (e.g., monomer unit M3) to form initial polymer hydrogel 14'. In these examples, initial polymer hydrogel 14' can be composed of (M1) n (M2) m (M3) q In the corresponding cationic polymer hydrogel 14, M1 can be represented by M1' (refer to Figure 3 said) or M1" (reference Figure 4), but M2, M3, n, m and q are the same as those described for the initial polymer hydrogel 14'.

[0097] In some examples, the initial polymer hydrogel 14'((M1) n (M2) m or (M1) n (M2) m (M3) q ) (and the corresponding cationic polymer hydrogel 14) can be a linear copolymer or a lightly cross-linked copolymer. The molecular weight of the initial polymer hydrogel 14' can be in the range of about 10 kDa to about 1500 kDa, or in specific examples can be about 312 kDa or about 500 kDa. The molecular weight of the cationic polymer hydrogel 14 can be higher than that of its corresponding initial polymer hydrogel 14', depending on the cationic moiety 16 integrated therein or the cationic moiety 16 and the linker attached thereto.

[0098] One of ordinary skill in the art will recognize that the recurring arrangements of "n" and "m" or "n," "m," and "q" features are representative and that the monomer subunits may be present in any order in the initial polymer hydrogel 14' / cationic polymer hydrogel 14 structure (e.g., random, block, patterned, or a combination thereof).

[0099] In order to introduce the initial polymer hydrogel 14' into the channel 20, a copolymer ((M1) n (M2) m or (M1) n (M2) m (M3) q ) and then applied to the substrate 12. In one example, the copolymer may be present in a mixture (e.g., with water or with a mixture of ethanol and water). The copolymer mixture may then be applied to the substrate surface 22 using spin coating or dipping or dip coating or material flow under positive or negative pressure or another suitable technique.

[0100] In some examples, substrate surface 22 (including the portion exposed in channel 20) can be activated and then the copolymer mixture can be applied thereto. In one example, silane or silane derivatives (e.g., norbornene silane) can be deposited on substrate surface 22 using vapor deposition, spin coating, or other deposition methods. In another example, substrate surface 22 can be exposed to plasma ashing to produce a surfactant (e.g., -OH groups) that can attach to the copolymer. In other examples, plasma ashing followed by silanization can be used to activate substrate surface 22.

[0101] Depending on the copolymer, the applied mixture may be exposed to a curing process to form an initial (covalently bonded) polymer hydrogel 14' on the surface 22. In one example, curing may be performed at a temperature ranging from room temperature (e.g., about 25° C.) to about 95° C. for a time ranging from about 1 millisecond to about several days. Polishing may then be performed to remove the initial polymer hydrogel 14' from the surface 22 at the perimeter of the substrate 12 while leaving the initial polymer hydrogel 14' on the surface 22 at least substantially intact in the channel 20.

[0102] Flow cell 10 P Amplification primer 18 is also included.

[0103] A grafting process can be performed to graft the amplification primer 18 to the initial polymer hydrogel 14' in the channel 20. In one example, the amplification primer 18 can be fixed to the initial polymer hydrogel 14' by a single point covalent attachment at or near the 5' end of the primer 18. This attachment allows i) the adapter-specific portion of the primer 18 to anneal freely to its cognate, ready-to-sequence nucleic acid fragment, and ii) the 3' hydroxyl group to be free for primer extension. Any suitable covalent attachment can be used for this purpose. Examples of capped primers that can be used include alkyne-terminated primers (e.g., which can be attached to the azide surface portion of the initial polymer hydrogel 14'), thiophosphate-terminated primers (e.g., which can be attached to the bromine surface portion of the initial polymer hydrogel 14'), or azide-terminated primers (e.g., which can be attached to the alkyne surface portion of the initial polymer hydrogel 14'). Specific examples of suitable primers 18 include the use of P5 and P7 primers on the surface of commercial flow cells sold by Illumina Inc. to sequence the HISEQ TM HISEQX TM MISEQ TM MISEQDX TM MINISEQ TM 、NEXTSEQ TM 、NEXTSEQDX TM 、NOVASEQ TM 、GENOME ANALYZER TM 、ISEQ TM and other instrument platforms.

[0104] In one example, grafting may involve flow-through deposition (e.g., using a temporarily bonded or permanently bonded cap), bubble coating, spray coating, whipped dispensing, or another suitable method by which the primer 18 is attached to the initial polymer hydrogel 14' in the channel 20. Each of these exemplary techniques may utilize a primer solution or mixture that may include a primer, water, a buffer, and a catalyst. Using any of the grafting methods, the primer 18 reacts with the reactive groups (e.g., the surface portion of the monomer unit M1) of the initial polymer hydrogel 14' in the channel 20 and has no affinity for the surrounding substrate 12. Thus, the primer 20 is selectively grafted to the initial polymer hydrogel 14' in the channel 20.

[0105] The concentration of the primer 18 in the primer solution or mixture is such that some surface portions of the monomer units M1 of the initial polymer hydrogel 14' remain available for interaction or reaction to introduce the cationic moieties 16 ( Figure 2B ).

[0106] like Figure 2A As shown, a fluid 24 including a positively chargeable portion 26 is introduced into the flow cell 10. P The initial polymer hydrogel 14' is incubated in the fluid 24 at a temperature sufficient to form a cationic polymer hydrogel 14 ( Figure 2B shown) for a period of time.

[0107] The fluid 24 and positively chargeable moiety 26 used may depend on the initial polymer hydrogel 14' and, in particular, on the surface portion of the monomer units M1 in the initial polymer hydrogel 14'. The incubation temperature and time may also depend on the positively chargeable moiety 26 and the initial polymer hydrogel 14'.

[0108] Some examples of the positively chargeable moiety 26 integrate themselves into the monomer unit M1 of the initial polymer hydrogel 14' to form a cationic polymer hydrogel 14 including the cationic moiety 16. When the cationic moiety 16 is "integrated into the monomer unit of the initial polymer hydrogel", it means that the cationic moiety 16 has replaced a surface portion of the monomer unit M1 of the initial polymer hydrogel 14'. In this example, the surface portion is a negatively chargeable atom, and the positively chargeable moiety 26 is a stronger redox species than the negatively chargeable atom. For example, the negatively chargeable atom of the monomer unit M1 is bromine, and the positively chargeable moiety is selected from the group consisting of: tris(hydroxymethyl)phosphine, tris(hydroxypropyl)phosphine, tetrakis(hydroxymethyl)phosphine, and tris(2-carboxyethyl)phosphine. Any of these phosphine positively chargeable moieties can replace the bromine atom of the monomer unit M1 of the initial polymer hydrogel 14', so that the corresponding phosphonium cation becomes the monomer unit M1' of the cationic polymer hydrogel 14 (see Figure 3) moiety. Table 1 shows the positively chargeable moiety 26 for the bromine displacement reaction and the corresponding cation incorporated into the monomer unit M1' of the cationic polymer hydrogel 14. In each of these examples, the counterion is bromide (Br - ).

[0109] Table 1

[0110] Positively charged part Corresponding cation Tris(hydroxymethyl)phosphine Tris(hydroxymethyl)phosphonium cation Tri(hydroxypropyl)phosphine Tri(hydroxypropyl)phosphonium cation Tetrakis(hydroxymethyl)phosphine Tetrakis(hydroxymethyl)phosphonium cation Tris(2-carboxyethyl)phosphine Tris(2-carboxyethyl)phosphonium cation

[0111] Examples of displacement reactions are Figure 3 . In this example, the initial polymer hydrogel 14' is a silane-free acrylamide, including N-(5-bromoacetamidopentyl)acrylamide as the first monomer unit M1 and acrylamide as the second monomer unit M2. When exposed to a fluid 24 including a positively chargeable moiety 26 (which is tri(hydroxypropyl)phosphine in this example), the positively chargeable moiety 26 replaces the negatively chargeable atoms of the initial polymer hydrogel 14'. The result of the replacement reaction is a cationic polymer hydrogel 14, which includes a cationic moiety 16 (which is a tri(hydroxypropyl)phosphonium cation in this example) attached to the monomer unit M1', wherein bromine has been attached to the monomer unit M1.

[0112] exist Figure 3 In the example shown, the fluid 24 may include a buffer having a pH in the range of 6 to 12. For example, the buffer may be a Tris buffer or an ethanolamine buffer. The concentration of the positively chargeable moiety 26 in the fluid 24 may be in the range of about 1 mM to about 500 mM. In one example, the concentration of the positively chargeable moiety 26 in the fluid 24 may be in the range of about 50 mM to about 400 mM. In another example, the concentration of any phosphine positively chargeable moiety 26 in the fluid 24 may be about 100 mM.

[0113] In this example, the incubation temperature is in the range of about 18°C ​​to about 65°C, and the incubation time is in the range of about 1.5 minutes to about 5 minutes.

[0114] It should be understood that Figure 3 The exemplary reaction shown is an example of a displacement reaction, and other monomer units M1 (eg, including another displaceable surface moiety), M2, and / or other positively chargeable moieties 26 may be used.

[0115] Other examples of positively chargeable moieties 26 are provided by linkers 28 ( Figure 4) is attached to the monomer unit M1 of the initial polymer hydrogel 14' to form a cationic polymer hydrogel 14 including a cationic portion 16. When the cationic portion 16 is "attached to the monomer unit of the polymer hydrogel through a linker", it means that the surface portion of the monomer unit M1 of the initial polymer hydrogel 14' reacts with the linker 28 to attach the cationic portion 16.

[0116] In this example, the surface moiety is an azide group or an alkyne group, and the positively chargeable moiety 26 is covalently attached to the surface moiety via an organic linker 28. In one example, the surface moiety (of monomer unit M1) includes a terminal azide group, and the linker 28 includes an alkyne group. In another example, the surface moiety (of monomer unit M1) includes a terminal alkyne group, and the linker 28 includes an azide group.

[0117] In addition to the azide group or the alkyne group, the linker 28 may also include a chain, which may be a single -CH2- unit, may include several -CH2- units, several CH2CH2O- units, an oligonucleotide chain, or another polymer chain. In one example, the linker 28 is a bifunctional DNA oligonucleotide. By "bifunctional", it is meant that one end of the DNA oligonucleotide linker has one end group that can be attached to the initial polymer hydrogel 14' and another end group that can be attached to the cationic portion 16.

[0118] Any example of a linker 28 may also be cleavable. By "cleavable" is meant that the linker 28 includes a cleavable bond, so that the cationic portion 16 can be removed from the surface of the flow cell. For example, the linker 28 may include a cleavable disulfide bond, a photolyzable bond, a cleavable phosphodiester bond, or a combination thereof. For example, the phosphodiester bond of a DNA oligonucleotide may be cleaved via enzymatic cleavage. For another example, the linker 28 may include a cleavable disulfide bond (SS) or a photolyzable bond (e.g., a linker including a nitrobenzyl group, such as a photolyzable spacer:

[0119]

[0120] (available from Integrated DNA Technologies). In one example, the cleavable bond is between the terminal azide or alkyne group and the positively chargeable moiety 26. A cleavable bond in the linker 28 may be desirable so that the cationic moiety 16 can be removed from the cationic polymer hydrogel 14, for example, after seeding library fragments, after DNA is extracted from a lysate, etc. Cleavage of the cationic moiety 16 will remove the positive charge, and the flow cell surface will revert to its original charge state (e.g., the charge prior to the introduction of the cationic moiety 16).

[0121] In this example, the positively chargeable moiety 26 can be any group that carries or can carry a positive charge and can be attached to the linker 28. For example, the positively chargeable moiety 26 can be a group that can carry a positive charge at physiological pH (thus generating a protonated amine group: R-NH3 + Amine groups as cationic moieties 16), such as polylysine, polyamidoamine, etc., or can carry a positive charge at most pHs (thus generating quaternary ammonium cations: As the cation part 16), a quaternary ammonium salt, or a sulfonium ion: In some examples, the initial polymer hydrogel 14 ′ may include a combination of different positively chargeable moieties 26 .

[0122] In some examples, the positively chargeable moiety 26 is attached to the linker 28, and the resulting compound 30 ( Figure 4 ) is introduced into the flow cell 10 P of fluid 24 to generate a cationic polymer hydrogel 14. These compounds 30 are commercially available or can be synthesized. As an example of a suitable compound 30, an azide-containing or alkyne-containing linker 28 can be attached to any of the R groups of an amine group, a quaternary ammonium group, or a sulfonium ion. An example of a compound 30 is propargyl choline bromide:

[0123]

[0124] It includes an alkyne linker 28 attached to an N,N,N-trimethylethanolammonium cation, which is a choline species of a quaternary ammonium cation. Other examples of compound 30 include azidoethyl-SS-ethylamine:

[0125]

[0126] It includes an azide-containing linker 28 attached to an amine group (which can form a protonated amine), or propargyl-SS-ethylamine:

[0127]

[0128] It includes an alkyne-containing linker 28 attached to an amine group (which can form a protonated amine). These two specific linkers 28 include an azide group (N3) or an alkyne group (C≡C) and a cleavable disulfide bond (SS) in the alkyl chain.

[0129] An example of using a linker 28 to attach a positively chargeable moiety 26 to an initial polymer hydrogel 14' is shown in Figure 4. In this example, the initial polymer hydrogel 14' includes N-(5-azidoacetamidopentyl)acrylamide as the first monomer unit M1 and acrylamide as the second monomer unit M2. When exposed to a fluid 24 including a positively chargeable portion 26 (which in this example is propargyl choline bromide), the azide group of the first monomer unit M1 and the alkyne group of the compound 30 undergo a copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. The result of the CuAAC reaction is a cationic polymer hydrogel 14, which includes a cationic portion 16 of a triazole attached to the monomer unit M1' (which in this example is an N,N,N-trimethylethanolammonium cation).

[0130] exist Figure 4 In the example shown, the fluid 24 may include water. The concentration of the compound 30 in the fluid 24 may be in the range of about 100 nM to about 100 μM. Because the ligation reaction is a CuAAC reaction, the fluid 24 may also include a catalyst and a ligand, or a catalyst, a ligand, and a reducing agent. These components may be added to the fluid 24 so that they are introduced into the flow cell 10. P Any copper catalyst that produces copper (II) ions, such as CuSO4, can be used. Any ligand, such as N,N,N',N",N"-pentamethyldiethylenetriamine (PMDTA) can be used. Any reducing agent, such as sodium ascorbate, can be used. In one example, fluid 24 includes about 0.25 mol % to about 2 mol % of the copper catalyst and about 5 mol % to about 10 mol % of the reducing agent.

[0131] In this example, the incubation temperature is in the range of about 18°C ​​to about 60°C, and the incubation time is in the range of about 30 minutes to about 12 hours. For another example, the incubation temperature of the CuAAC reaction is in the range of about 18°C ​​to about 22°C, and the time is in the range of about 60 minutes (1 hour) to about 6 hours or about 6 hours to about 12 hours.

[0132] It should be understood that Figure 4 The exemplary reaction shown is one example of an attachment reaction, and other monomer units M1, M2, other linkers 28, and / or other positively chargeable moieties 26 may be used.

[0133] In other examples, Figure 3 and Figure 4 A combination of the methods shown in can be used to generate a cationic polymer hydrogel 14 including a cationic portion 16. An example is Figure 5A and Figure 5B Shown in.

[0134] In this example, a linker 28' comprising a terminal azide or alkyne at one end and a terminal negatively chargeable atom (e.g., bromine, iodine, or another weak nucleophile) at the other end is attached to a surface portion of a monomer unit M1 of the initial polymer hydrogel 14'. When the linker 28' comprises a terminal azide, the surface portion of the monomer unit M1 is an alkyne, and when the linker 28' comprises a terminal alkyne, the surface portion of the monomer unit M1 is an azide. The linking reaction can be as described in reference Figure 4 This produces a modified polymer hydrogel 14", such as Figure 5A shown.

[0135] The modified polymer hydrogel 14" can then be exposed to Figure 3 The displacement reaction described above. A fluid 24 including a more positively chargeable moiety 26 than the negatively chargeable atoms (e.g., bromine) of the modified polymer hydrogel 14" may be introduced into the flow cell 10. P In. As reference Figure 3 As described, the positively chargeable moieties 26 will displace and replace the negatively chargeable atoms to form another example of a cationic polymer hydrogel 14 .

[0136] When the incubation is carried out at a certain temperature for a suitable time, a cationic polymer hydrogel 14 (such as Figure 5B ), which includes a cationic portion 16 and an amplification primer 18 on its surface.

[0137] It should be understood that Figure 5A and Figure 5B The exemplary reaction shown is one example of a displacement and attachment reaction, and other monomer units M1 (eg, including another displaceable surface moiety), M2, other linkers 28, and / or other positively chargeable moieties 26 may be used.

[0138] The flow cell 10 having a positively charged (cationic) polymer hydrogel 14 is Figure 2B Shown in. Figure 2B The flow cell 10 shown includes: a substrate 12; a cationic polymer hydrogel 14 on the substrate 12; a cationic portion 16, which is i) integrated into the monomer unit M1' of the cationic polymer hydrogel 14, or ii) attached to the monomer unit M1' of the polymer hydrogel 14 through a linker 28, 28'; and an amplification primer 18 attached to the cationic polymer hydrogel 14.

[0139] The positively charged polymer hydrogel 14 can attract negatively charged complexes or samples introduced into the flow cell 10, thus eliminating the need to utilize additional capture sites.

[0140] Additional flow cell configurations

[0141] Although in Figure 2B One example of a flow cell configuration is shown in FIG, but it should be understood that other flow cell configurations may be used.

[0142] Another example of a flow cell 10' is Figure 6 This example is similar to Figure 2B The example shown, however, differs in that the substrate 12 includes a plurality of recesses 32 separated by void areas 34, and the cationic polymer hydrogel 14 (including the cationic portion 16) and the amplification primer 18 are located within each of the recesses 32. Figure 6 In the example shown, a recess 32 is defined in the channel 20 .

[0143] In this example, the recesses 32 can be patterned into the substrate 12. Patterning can involve etching the recesses 32 into the substrate 12 and / or using imprint lithography. The recesses 32 can then be functionalized with the cationic polymer hydrogel 14 (including the cationic portion 16) and the amplification primer 18 as described herein. The void regions 34 between the recesses 32 do not have the cationic polymer hydrogel 14 (including the cationic portion 16) or the amplification primer 18. This may be due to the initial polymer hydrogel 14' having been polished from the void regions 34. After the recesses 32 are functionalized, additional materials 36 (e.g., hydrophobic materials) can be attached (e.g., bonded, adhered, etc.) to the substrate 12 (e.g., at the periphery) to define the walls of the channel 20 around the recesses 32.

[0144] Recessed portion 32 can be distributed on whole circulation pool 10 ' with any suitable pattern or layout.When circulation pool 10 ' comprises multiple passages 20, the pattern of recessed portion 32 can be identical, or the different patterns of recessed portion 32 can be used in different passages 20.Many different patterns / layouts of recessed portion 32 can be envisioned, including regular, repeated and irregular patterns.In one example, recessed portion 32 is arranged in hexagonal grid, so as to closely pack and improve density.Other layouts can include, for example, parallelogram layout (that is, rectangle, square etc.), triangle layout, circular layout etc.

[0145] Each recess 32 may have any suitable shape (and corresponding three-dimensional geometry), such as a circle (e.g. Figure 6 as shown), ellipse, polygon (e.g., triangle, quadrilateral, pentagon, etc.), etc.

[0146] The size of each recess 32 may be characterized by its open area, diameter, and / or length and width.

[0147] The area occupied by each recess opening can be selected so that the complex cannot enter the recess 32. In one example, the area of ​​each recess opening can be at least about 1×10 -4 μm 2 , at least 1×10 -3 μm 2 , at least about 1×10 -2 μm 2 , at least about 0.1 μm 2 , at least about 0.5 μm 2 , at least about 1 μm 2 or at least about 4 μm 2 The area occupied by each recess opening may be less than the values ​​specified above or between them.

[0148] In some cases, the diameter or length and width of each recess 32 can be at least about 1 nm, at least about 50 nm, at least about 100 nm, at least about 500 nm, or more, as long as the size is smaller than the channel diameter or length and width. An example of a recess diameter is in the range of about 1 nm to about 500 nm. Another example of a recess diameter is in the range of about 300 nm to about 2 μm.

[0149] The recessed portion 32 may also have a depth. For example, the depth of each recessed portion 32 may be at least about 10 nm, at least about 50 nm, at least about 1 μm, or at most about 2 μm. It should be understood that the depth of each recessed portion 32 may be greater than, less than, or between the values ​​specified above.

[0150] In one example, the aspect ratio (diameter:depth) of the recessed portion 32 may be in a range of about 1:1 to about 1:2 or about 1:1.25 to about 1:1.75.

[0151] In this example, adjacent recesses 32 may be separated by void areas 34 within a given channel 20. The average recess pitch represents the spacing from the center of one recess 32 to the center of an adjacent recess 32 (center-to-center spacing) or the spacing from the right edge of one recess 32 to the left edge of an adjacent recess 32 (edge-to-edge spacing). The layout or pattern of the recesses 32 may be regular, so that the coefficient of variation around the average pitch is small, or the layout or pattern may be irregular, in which case the coefficient of variation may be relatively large. In either case, the average pitch may be, for example, at least about 10 nm, at least about 0.1 μm, at least about 0.5 μm, or more, depending on the size of the channel 20. Alternatively or in addition, the average pitch may be, for example, at most about 0.5 μm, at most about 0.1 μm, or less. The average pitch of a particular pattern of recesses 32 may be between one of the lower limit values ​​and one of the upper limit values ​​selected from the above range.

[0152] Another example of a flow cell 10" is Figure 7 This example is similar to Figure 6 The example shown differs in that the substrate 12 further includes a plurality of chambers 38, 38', and wherein a subset of the plurality of recesses 32 is located within the perimeter of each of the plurality of chambers 38, 38'. Figure 6 , the cationic polymer hydrogel 14 (including the cationic portion 16 ) and the amplification primer 18 are located within each of the recessed portions 32 .

[0153] In this example, the recesses 32 can be patterned into the substrate 12. Patterning can involve etching the recesses 32 into the substrate 12 and / or using imprint lithography. The recesses 32 can then be functionalized with the cationic polymer hydrogel 14 (including the cationic portion 16) and the amplification primer 18 as described herein. The void areas 34 between the recesses 32 do not have the cationic polymer hydrogel 14 (including the cationic portion 16) or the amplification primer 18. After the recesses 32 are functionalized, additional materials 36 (e.g., hydrophobic materials) can be attached (e.g., bonded, adhered, etc.) to the substrate 12 (e.g., at the periphery) to define the walls of the chambers 38, 38' around the subset of the recesses 32.

[0154] The chambers 38, 38' can be distributed throughout the substrate 12 in any suitable pattern or layout. Many different layouts of the chambers 38, 38' are contemplated, including regular, repeated, and irregular patterns. In one example, the chambers 38, 38' are arranged in a hexagonal grid for close packing and improved density. Other layouts may include, for example, parallelogram layouts (i.e., rectangular, square, etc.), triangular layouts, circular layouts, etc. In some examples, the layout or pattern may be an xy format of chambers 38, 38' in rows and columns.

[0155] The chambers 38, 38' may have any suitable shape, such as square, circular, oval, polygonal (eg, triangular, quadrilateral, pentagonal, etc.), etc.

[0156] The size of each chamber 38, 38' may be characterized by its opening area, diameter and / or length and width. Figure 7 As shown, the flow cell 10" has a plurality of recesses 32 located within each of the chambers 38, 38'. Therefore, the size of the chambers 38, 38' is greater than the size of each recess 32. In other words, one or more dimensions of the chambers 38, 38' are greater than one or more dimensions of each recess 32. In this example, "size" refers to the area occupied by each chamber opening or recess opening, and / or the diameter of the chamber 38, 38' or recess 32, and / or the length and width of each chamber 38, 38' or recess 32. Figure 7In the example shown, the opening area and diameter of each chamber 38, 38' are greater than the opening area and diameter of each recess 32. The opening area and diameter or length and width of each chamber 38, 38' depends on the number of recesses 32 to be located within the chamber 38, 38'.

[0157] The area occupied by each chamber opening can be selected so that the complex (exemplified in FIG. 8A to FIG. 8C In one example, the area of ​​each chamber opening may be at least about 1 μm 2 , at least about 10 μm 2 , at least about 100 μm 2 The area occupied by each chamber opening may be greater than the values ​​specified above or between them.

[0158] In some cases, the diameter or length and width of each chamber 38, 38' can be at least about 1 μm, at least about 10 μm, at least about 20 μm, at least about 30 μm, at least about 40 μm, at least about 50 μm, at least about 100 μm, or more. An example of a chamber diameter is in the range of about 1 μm to about 1000 μm. Another example of a chamber diameter is in the range of about 10 μm to about 50 μm. When chambers 38, 38' have a length and a width, it should be understood that the length and width can be the same or different.

[0159] Chambers 38, 38' may also have a depth, which depends on the technology used to form chambers 38, 38'. For example, when microcontact, aerosol or inkjet printing is used to deposit additional materials 36 defining chambers 38, 38', the depth of each chamber 38, 38' may be a single layer thick. For other examples, the depth of each chamber 38, 38' may be about 1 μm, about 10 μm, about 50 μm or more. In another example, the depth is at least about 50% of the average diameter of the complex to be introduced into chambers 38, 38'. In one example, the depth may be in the range of about 10 μm to about 30 μm. In addition to attracting the positively charged polymer hydrogel 14 of the released library fragments, the depth of chambers 38, 38' may help block the lateral diffusion of the released library fragments between adjacent chambers 38, 38'. Therefore, the released library fragments may be kept in chambers 38, 38' without any external fixative. In another example, the depth is about 5 μm or less. It should be understood that the depth of each chamber 38, 38' may be greater than, less than, or between the values ​​specified above.

[0160] Adjacent chambers 38, 38' may be separated by the surface of the additional material 36. The average chamber pitch represents the spacing from the center of one chamber 38, 38' to the center of the adjacent chamber 38, 38' (center-to-center spacing) or the spacing from the right edge of one chamber 38, 38' to the left edge of the adjacent chamber 38, 38' (edge-to-edge spacing). The layout or pattern of the chambers 38, 38' may be regular, so that the coefficient of variation around the average pitch is small, or the layout or pattern may be irregular, in which case the coefficient of variation may be relatively large. In either case, the average pitch may be, for example, at least about 1 μm, at least about 5 μm, at least about 10 μm, at least about 100 μm or more. In one example, the average pitch is 2 times the diameter of the chamber 14. The average pitch of a particular pattern of chambers 38, 38' may be between one of the lower limit values ​​and one of the upper limit values ​​selected from the above range. Although exemplary average chamber pitch values ​​have been provided, it should be understood that other average chamber pitch values ​​may be used.

[0161] Each subset of the recesses 32 is located within the perimeter of each of the plurality of chambers 38 , 38 ′.

[0162] Although not in Figure 6 or Figure 7 , but each chamber 38, 38' of the channel 20 of the flow cell 10' or the flow cell 10" may include a capture site that can attract a complex or sample introduced into the flow cell 10' or 10". More specifically, at least a portion of the void area 34 within the channel 20 or chamber 38, 38' may include a capture site.

[0163] The capture sites may be physically and / or chemically capable of immobilizing a complex or sample on the substrate 12 (eg, on the void region 34) in the channel 20 or chamber 38, 38'.

[0164] The capture sites may be located at any suitable location. The locations of the capture sites across the substrate 12 may be uniform or may be non-uniform. The capture sites may have any suitable shape, geometry, and size, which may depend at least in part on the configuration of the capture site (e.g., patch, hole, protrusion, etc.), and the type of complex or sample to be captured by the capture site.

[0165] In some examples, the capture site is a chemical capture agent applied to a portion of the void region 34. Any example of a chemical capture agent disclosed herein can be used. In one example, microcontact printing or another suitable technique can be used to deposit the corresponding chemical capture agent at the desired location.

[0166] In other examples, the capture site comprises a hole defined in the surface of the substrate 12. The hole can be formed using etching or stamping depending on the substrate 12 used. The hole can have any suitable shape and geometry, such as those described herein for the recessed portion 32. In some examples, the hole does not have an additional chemical capture agent added thereto. In these examples, the opening size enables the complex or sample to self-assemble into the corresponding hole (e.g., based on the shape). In other examples, the hole does have a chemical capture agent added thereto.

[0167] Other examples of capture sites include holes and capture beads with chemical capture agents on their surfaces. The size of the capture beads can be set to fit into the hole. In some examples, the capture beads may be coplanar with the adjacent void area 34 or extend slightly above it so that the complex or sample ultimately attached thereto is not confined within the hole. In one example, the capture beads are selected from the group consisting of silica, superparamagnetic materials, polystyrene, and acrylates. Any example of the chemical capture agent disclosed herein can be used on the surface of the capture beads and can be coated on the capture beads before the capture beads are introduced into the hole.

[0168] The depth of the capture site hole can vary depending on whether a chemical capture agent is to be introduced therein and whether a capture bead is to be introduced therein. The depth can be selected to at least accommodate these materials (i.e., contain the materials within the hole). In one example, the depth of the hole is in the range of about 1 nm to about 5 microns.

[0169] As another example, the capture site includes a protrusion defined in the substrate 12. The protrusion is a three-dimensional structure extending outward (upward) from the adjacent surface. The protrusion can be produced via etching, photolithography, embossing, etc. Although any suitable three-dimensional geometry can be used for the protrusion capture site, a geometry with at least a substantially flat top surface may be desired. Exemplary protrusion geometries include spheres, cylinders, cubes, polygonal prisms (e.g., rectangular prisms, hexagonal prisms, etc.), etc.

[0170] Different chemical capture agents can be applied on the top surface of the corresponding protrusion capture sites.Any of the examples of chemical capture agents disclosed herein can be used, and any deposition technique can be used to apply the chemical capture agent to the top surface of the protrusion.

[0171] It should be understood that any combination of capture site types may be used together on the flow cell 10', 10" (eg, capture agents and pores).

[0172] The flow cell 10, 10', 10" is also shown without a cover bonded to the substrate 12. It should be understood that some examples of the flow cell 10, 10', 10" may have a cover bonded to at least a portion of the substrate 12 (e.g., at the surface 22). The cover may be located on the surface 22 so that it defines a single flow channel 20 or a plurality of fluidically separated flow channels 20, or a plurality of chambers 38, 38' that may or may not be fluidically separated.

[0173] The cover can be any material that is transparent to the excitation light directed to the substrate 12. For example, the cover can be glass (e.g., borosilicate, fused silica, etc.), plastic, etc. A commercially available example of a suitable borosilicate glass is D Commercially available examples of suitable plastic materials (ie, cycloolefin polymers) are available from Zeon Chemicals LP. product.

[0174] The cover may be bonded to the substrate surface 22 using any suitable technique, such as laser bonding, diffusion bonding, anodic bonding, eutectic bonding, plasma activated bonding, glass frit bonding, or other methods known in the art. In one example, a spacer layer may be used to bond the cover to the substrate surface 22. The spacer layer may be any material that seals at least some of the substrate 12 and the cover together.

[0175] In other examples, the flow cell 10, 10', 10" does not include a cover, but instead includes two substrates 12 bonded together. In these examples, the reactive surfaces of the substrates 12 (e.g., polymer hydrogel 14, primer 18) face each other. The substrates 12 can be bonded together using similar techniques and materials described for the cover and substrates 12.

[0176] Reagent test kit

[0177] Flow cell 10 P It can be part of a kit that can be used to introduce positive charges into the initial polymer hydrogel 14'. In one example, the kit includes i) a flow cell 10 P , the flow cell comprises: a substrate 12; an initial polymer hydrogel 14', which is located on the substrate 12 and has a surface portion selected from the group consisting of negatively chargeable atoms, azide groups and alkyne groups; and an amplification primer 18 attached to the initial polymer hydrogel 14'; and ii) a fluid 24 including a positively chargeable portion 26, which will interact or react with the surface portion to form a cationic polymer hydrogel 14 including a cationic portion 16.

[0178] Any of the examples of flow cell configurations disclosed herein (including those for flow cells 10, 10', 10") may be used for flow cells 10 in the kit. P In addition, any examples of the substrate 12, the initial polymer hydrogel 14', and the amplification primer 18 may be used. In addition, any example of the fluid 24 including the positively chargeable portion 26 may be used in the kit.

[0179] The kit can be used to perform method 100 as described herein.

[0180] Complexes for use with flow cells

[0181] Examples of flow cells 10, 10', 10" may be particularly suitable for use with examples of complexes disclosed herein. The complexes include a support (e.g., a hydrogel support or a solid support) and a sequencing-ready nucleic acid fragment attached to or contained within the support. Examples of suitable complexes are described in FIG. 8A to FIG. 8C Although some exemplary methods for preparing the complexes are described, it should be understood that other methods can be used as long as the sequencing-ready nucleic acid fragments can be attached to or contained within the vector.

[0182] Fig. 8A Complex 40A is shown, which includes a solid support 42 and a sequencing-ready nucleic acid fragment 44 attached to the solid support 42 .

[0183] In one example, to form the complex 40A, a linker sequence 52, 52' is bound to a solid support 42 via one member 46 of a binding pair. In one example, the linker sequence 52, 52' includes a first sequencing primer sequence (e.g., a read 1 sequencing primer sequence) and a first sequence (e.g., a uracil-modified P5 sequence) complementary to at least a portion of one of the amplification primers 18 (e.g., P5) on the flow cell 10, 10', 10". The linker sequence 52, 52' is bound to one member 46 of a binding pair (e.g., biotin) so that it can be bound to a surface of a solid support 42 (which includes the other member of the binding pair (e.g., avidin, streptavidin, etc.). The linker sequence may also include an index sequence.

[0184] The Y-linker can be mixed with a transposase (e.g., two Tn5 molecules) to form a transposome. The Y-linker may include two mosaic end sequences that hybridize to each other. One of the mosaic end sequences may be attached to another linker 48, 48', which includes a second sequencing primer sequence (e.g., a read 2 sequencing primer sequence), a second sequence complementary to at least a portion of another one of the amplification primers 18 (e.g., P7) on the flow cell 10, 10', 10", and an optional index / barcode sequence.

[0185] The labeling process can then be performed. A fluid (e.g., labeling buffer) including a sample (e.g., DNA) can be added to a transposome and a solid support 42 having a linker sequence 52, 52' bound thereto. When the sample contacts the transposome, the DNA is labeled (fragmented and labeled by the linkers 52, 52' on the solid support 42), and is bound to the Y-linker (e.g., by connection of free mosaic end sequences). The continuous labeling of the sample results in the presence of multiple bridging molecules between the transposomes. The bridging molecules are wrapped around the solid support 42. The transposome maintains the adjacency of the bridging molecules. In order to complete the ready-to-use sequencing fragment 44, further extension and connection are performed to ensure that the sample fragments 50, 50' are attached to the sequences 48 and 48'.

[0186] The transposase can then be removed via sodium dodecyl sulfate (SDS) treatment or heat or proteinase K digestion. Removal of the transposase leaves the sequencing-ready nucleic acid fragments 44 attached to the solid support 42 .

[0187] The resulting complex 40A Fig. 8A . The bridging molecules are ready-to-sequence nucleic acid fragments 42, each of which includes a fragment 50, 50' and a connector sequence 48 and 52 or 48' and 50' attached at either end. The connector sequences 52, 52' are those initially bound to the solid support 42, and include a first sequencing primer sequence and a first sequence complementary to a flow cell primer. The connector sequences 52, 52' are attached to a member 46 of the binding complex / pair. The connector sequences 48, 48' are from a Y-connector and include a second sequence complementary to another flow cell primer and a second sequencing primer sequence. Because each ready-to-sequence nucleic acid fragment 44 includes a suitable connector for amplification (e.g., bridge amplification) and sequencing, PCR amplification is not performed. Therefore, these fragments 44 are ready-to-sequence. In addition, because the library fragments 44 are from the same sample, the fragments 44 are suitable for long read applications of connection.

[0188] Figure 8B Another complex 40B is shown, which includes a solid support 42 and a ready-to-sequence nucleic acid fragment 44' attached to the solid support 42. In one example, a PCR-free nucleotide library is created in a tube and then hybridized to the solid support 42 in the tube. Figure 8BIn the example shown, primers with one member 46 of a binding pair (e.g., adapters 52", 48") are added to the library fragments 50" in a tube, and then the sequencing-ready nucleic acid fragments 44' are bound to the solid support 42. In another example, the solid support 42 can have primers attached to it via a binding pair (e.g., avidin on the support 42 and biotin attached to the primers). These primers hybridize to the adapters 52" attached to the library fragments 50" (so the primers and binding pair members are at one end of the fragments but not the other). In another example, extension can be performed using a strand displacement enzyme. This will produce a completely double-stranded library (e.g., no forks or Y-adapters, such as Figure 8B The ready-to-sequence nucleic acid fragments 44' can be released onto the flow cell via denaturation.

[0189] Figure 8C An example of a complex 40C is shown, which includes a hydrogel support 54 and a sequencing-ready nucleic acid fragment 44" contained within the hydrogel support 54.

[0190] To form the complex 40C, a fluid containing hydrogel monomers and / or polymers and a crosslinking agent is mixed in the presence of a sample (e.g., genetic material). The fluid may be loaded into mineral oil or another suitable hydrophobic fluid and emulsified to produce droplets. A free radical initiator may be added to polymerize and / or crosslink the hydrogel monomers and / or polymers and form a hydrogel support 54.

[0191] When forming complex 40C, the fluid can be water; the monomer can be selected from the group consisting of acrylamide, N,N'-bis(acryloyl)cystamine, bisacrylamide, diacrylate, diallylamine, triallylamine, divinyl sulfone, ethylene glycol diallyl ether, ethylene glycol diacrylate, trimethylolpropane trimethacrylate, ethoxylated trimethylol diacrylate, ethoxylated pentaerythritol tetraacrylate, collagen monomer and combinations thereof; and / or the polymer can be selected from the group consisting of polyethylene glycol-thiol, polyethylene glycol-acrylate, polyethylene glycol diacrylate, poly Ethylene glycol (e.g., having a weight average molecular weight in the range of about 100 to about 200,000), polypropylene oxide, polyacrylic acid, poly(hydroxyethyl methacrylate), poly(methyl methacrylate), poly(N-isopropylacrylamide), poly(lactic acid), poly(lactic-co-glycolic acid), polycaprolactone, poly(vinyl sulfonic acid), poly(L-aspartic acid), poly(L-glutamic acid), polylysine, agar, agarose, alginate, heparin, sulfated alginate, dextran sulfate, hyaluronic acid, pectin, carrageenan, gelatin, chitosan, cellulose, collagen polymers, and combinations thereof. The crosslinking agent forms bonds, such as disulfide bonds, in the polymers of the hydrogel support 54. The crosslinking agent can be reversible in that it can be crosslinked and non-crosslinked, depending on the chemical to which it is exposed. For example, the reversible crosslinker is a bisacrylamide crosslinker containing a disulfide bond, which can be decomposed with a reducing agent such as dithiothreitol (DTT), tris-(2-carboxyethyl) phosphine (TCEP) or tris-(3-hydroxypropyl) phosphine (THP). In one example, the crosslinker is selected from the group consisting of acrylamide, N,N'-bis(acryloyl) cystamine, bisacrylamide, 1,4-diacryl piperazine, N-N'-diallyl L-tartaric acid diamide and N-N'-(1,2-dihydroxyethylene)-bisacrylamide. In one example, the free radical initiator can be a photoinitiator. Examples of photoinitiators include azobisisobutyronitrile, benzoyl peroxide, and eosin-5-isothiocyanate. This type of free radical initiator can be used because it only initiates crosslinking when exposed to light of an appropriate wavelength. In another example, the free radical initiator can initiate crosslinking when exposed to a free radical source. An example of this type of free radical initiator is tetramethylethylenediamine (TEMED).

[0192] The sample is encapsulated in the hydrogel support 54 because its size is sufficient to prevent it from passing through the pores of the hydrogel support 54. In some examples, the sample is DNA or RNA and is at least about 100 nucleotides in length (e.g., 1,000 nucleotides or more, 10,000 nucleotides or more, 500,000 nucleotides or more, etc.). In some examples, the pore size of the hydrogel support 54 refers to the average diameter or average effective diameter of the cross section of the pore based on the results of the measurement of multiple pores. The effective diameter of a non-circular cross section is equal to the diameter of a circular cross section having the same cross-sectional area as the non-circular cross section. In one example, the pore size is in the range of about 10 nm to about 100 nm.

[0193] Library preparation can then be performed within the hydrogel support 54. Multiple reagent exchanges can occur through the pores of the hydrogel support 54. The sample and any library fragments generated therefrom are maintained within the hydrogel matrix. Library preparation can involve fragmenting the sample and adding adapters that will generate ready-to-sequencing fragments 44".

[0194] In one example, library preparation can be performed via labeling that occurs within the hydrogel support 54. The resulting complex 40C is Figure 8C . The adapter sequence includes suitable adapters for amplification and sequencing, so the resulting fragments 44" are ready for sequencing. As another example, library preparation can be performed using polymerase extension, which will produce a double-stranded library. This exemplary library requires denaturation before release from the hydrogel support 54 and inoculation.

[0195] Methods involving complexes

[0196] Some examples of the methods disclosed herein utilize examples of flow cells 10, 10', 10" disclosed herein and any of the complexes 40A, 40B or 40C. As described above, each of the complexes 40A, 40B or 40C includes ready-to-use sequencing fragments obtained from the same sample of genetic material. When one or more of the complexes are separated within the channel 20 or chamber 38, 38', spatial co-localization of libraries from the same sample is achieved.

[0197] In an exemplary method, the complex 40A, 40B or 40C is introduced into the flow cell 10, 10', 10", for example through one or more input ports. The complex 40A, 40B or 40C can be introduced into a fluid (such as Tris-HCl buffer or 0.5x saline sodium citrate (SSC) buffer). At least some of the complex 40A, 40B or 40C from the fluid will settle into at least some of the channel 20 and / or chambers 38, 38'. When the flow cell 10 is used, the negatively charged ready-to-use sequencing fragments 44, 44', 44" of the complex 40A, 40B or 40C can be attracted to the positively charged polymer hydrogel 14 in the channel 20. When the flow cell 10' or 10" is used, the positively charged polymer hydrogel 14 is confined in the recess 32. In some of these examples, the complex 40A, 40B, or 40C may settle and be retained in the channel 20 or chamber 38, 38' due in part to the depth of the channel 20 or chamber 38, 38'. In some other of these examples, the channel 20 or chamber 38, 38' may include a capture site to which the complex 40A, 40B, or 40C is attached.

[0198] It should be understood that some complexes 40A, 40B or 40C may not settle and these complexes 40A, 40B or 40C will be removed from the circulation pool 10, 10', 10" prior to further processing. It should also be understood that some channels 20 or chambers 38, 38' may receive one or more of the complexes 40A, 40B or 40C, while other channels 20 or chambers 38, 38' may not receive the complexes 40A, 40B or 40C. The distribution of the complexes 40A, 40B or 40C can be random when capture sites are not included, or can be more controlled when capture sites are included.

[0199] The exemplary method then includes washing the untrapped complexes 40A, 40B, or 40C from the flow cell 10, 10', 10". Washing may involve introducing a fluid into the flow cell 10, 10', 10". The flow may push any complexes 40A, 40B, or 40C that have not yet settled through the outlet of the flow cell 10, 10', 10".

[0200] This example of the method then includes causing the carrier (e.g., solid support 42 or hydrogel support 54) of the captured complex 40A, 40B, or 40C to release the sequencing-ready nucleic acid fragments 44, 44', or 44" into the corresponding channel 20 or chamber 38, 38' in which each complex 40A, 40B, or 40C is captured.

[0201] Causing the carrier (i.e., support 42 or 54) to release the ready-to-sequence nucleic acid fragments 44, 44' or 44" can vary depending on the complex 40A, 40B or 40C used. In one example, the carrier is a solid support 42, and the causing process involves introducing a cleavage agent into the circulation pool 10, 10', 10". The cleavage agent can trigger the chemical, enzymatic or photochemical release of the ready-to-sequence nucleic acid fragments 44, 44' from the solid support 42. In these examples, another stimulus (such as heat or light) can trigger the cleavage agent to release the library fragments 44 or 44' from the solid support 42. For example, free biotin can be introduced as a cleavage agent, and heating to about 92°C can be used to induce the release of biotin-oligonucleotides from the solid support 42.

[0202] In other examples, complex 40C is used and the carrier is a hydrogel support 54. In these other examples, causing library release may involve heating the circulation cell 10, 10', 10", introducing a cleavage agent into the circulation cell 10, 10', 10", or a combination thereof. Heating to release the library fragments 44" from the hydrogel support 54 may involve heating to a temperature of about 90°C. The entire circulation cell 10, 10', 10" may be heated, and when the complex 40C is heated, the hydrogel support 54 may degrade to release the fragments 44". In some examples, the cleavage agent may include one or more components that can depolymerize the hydrogel support 54 and release the ready-to-use sequencing fragments 44" therefrom. For example, the cleavage agent includes dithiothreitol (DTT), tris(2-carboxyethyl)phosphine (TCEP), or tris(3-hydroxypropyl)phosphine (THP). In other examples, the cleavage agent is light. In these examples, the cross-linking agent used to form the hydrogel support 54 may include a photolyzable moiety, and exposure of the complex 40C to light of an appropriate wavelength may cleave the moiety and degrade the hydrogel support 54 .

[0203] Transport and seeding of the ready-to-sequence nucleic acid fragments 44, 44' or 44" is controlled in part by the positive charge of the cationic polymer hydrogel 14. The ready-to-sequence nucleic acid fragments 44, 44', 44" are negatively charged and are therefore attracted to the positively charged polymer hydrogel 14. Therefore, the fragments 44, 44' or 44" of any particular complex 40A, 40B or 40C will be confined to the channel 20 or chamber 38, 38' where the particular complex 40A, 40B or 40C is confined.

[0204] In addition to the attraction of the cationic polymer hydrogel 14, the depth of the channel 20 or chamber 38, 38' can also limit the transport and seeding of the sequencing-ready nucleic acid fragments 44, 44' or 44" so that external fixatives are not introduced into the flow cell 10, 10', 10".

[0205] Using the flow cell 10, 10', 10" disclosed herein, the cationic polymer hydrogel 14 can attract the ready-to-sequence nucleic acid fragments 44, 44' or 44" immediately after the fragments are released, which enables the amplification primer 18 to inoculate the released ready-to-sequence nucleic acid fragments 44, 44' or 44" in a relatively defined manner. In one example, the inoculation is accomplished by hybridization between the first sequence or the second sequence of the fragment 44, 44' or 44" and the complementary primer in the primer 18. The inoculation can be performed at a suitable hybridization temperature for the fragment 44, 44' or 44" and the primer 18.

[0206] The seeded sequencing library can then be amplified using any suitable method, such as cluster generation.

[0207] In one example of cluster generation, a high-fidelity DNA polymerase is used to replicate the ready-to-sequence nucleic acid fragments 44, 44' or 44". from the hybridization primer 18 by 3' extension, and the original ready-to-sequence nucleic acid fragments 44, 44' or 44" are denatured, thereby fixing these copies in the channel 20 or recess 32. Isothermal bridge amplification can be used to amplify the fixed copies. For example, the replicated template loops back to hybridize with the adjacent complementary primer 18, and the polymerase replicates the replicated template to form a double-stranded bridge, and these double-stranded bridges are denatured to form two single strands. These two strands loop back and hybridize with the adjacent complementary primer 18, and are extended again to form two new double-stranded loops. The process is repeated for each template copy through isothermal denaturation and amplification cycles to produce dense clonal clusters. Each cluster of double-stranded bridges is denatured. In one example, the antisense strand is removed by specific base cleavage, leaving the forward template polynucleotide strand. It should be understood that clustering results in the formation of multiple template ready-to-sequence nucleic acid fragments in each channel 20 or recess 32.

[0208] After cluster generation, the cationic portion 16 can be cleaved from the cationic polymer hydrogel 14. Therefore, the charge on the surface of the flow cell can be considered to be reversible. The cleavage of the cationic portion 16 can be performed when the cationic portion 16 is cleavable or attached via a cleavable linker 28, 28' (e.g., including a cleavable disulfide bond or a photolyzable bond or a cleavable nucleotide bond). The cleavage of the cationic portion 16 can be achieved by photocleavage, by exposure to acidic conditions (e.g., if the linker is acid-labile) or by enzymatic cleavage (e.g., if a bifunctional DNA oligonucleotide is used as a linker 28, 28' to attach the cationic portion 16). The cleavage of the cationic portion 16 can reverse the charge on the surface of the flow cell, in part because the template attached to the polymer hydrogel 14, i.e., the sequencing nucleic acid fragment, is negatively charged.

[0209] After cluster generation (and in some cases, after cleavage of the cationic moiety 16), sequencing can be performed. Any example of the flow cell 10, 10', 10" disclosed herein can be used in a variety of sequencing methods or techniques, including techniques generally referred to as synthesis sequencing (SBS), cycle array sequencing, ligation sequencing, pyrophosphate sequencing, etc.

[0210] For example, a synthesis sequencing (SBS) reaction can be performed in a system such as HISEQ TM HISEQX TM MISEQ TM MISEQDX TM MINISEQ TM 、NOVASEQ TM 、NEXTSEQDX TM 、ISEQ TM 、NEXTSEQ TM Or run on other sequencing machine systems obtained from Illumina (San Diego, California). In SBS, the sequencing primer is monitored along the template, i.e., the extension of the sequencing nucleic acid fragment to determine the sequence of the nucleotides in the template. The 3' end of the primer 18 (not attached to the copy) bound to the template and any flow cell can be blocked to prevent interference with the sequencing reaction, and specifically, to prevent undesirable initiation. The basic chemical process can be polymerization (e.g., catalyzed by a polymerase) or connection (e.g., catalyzed by a ligase). In a specific polymerase-based SBS process, fluorescently labeled nucleotides are added to the sequencing primer in a template-dependent manner, so that the sequence of the template can be determined using the detection of the order and type of the nucleotides added to the sequencing primer. For example, in order to trigger the first SBS cycle, one or more labeled nucleotides, DNA polymerases, etc. can be delivered to / through the flow cell 10, etc., in which the sequencing primer extension causes the labeled nucleotides to be incorporated. This incorporation can be detected by imaging events. During imaging events, an illumination system (not shown) can provide excitation light to the flow cell 10, 10', 10".

[0211] In some examples, the fluorescently labeled nucleotides may further include a reversible termination property that terminates further primer extension once the nucleotides are added to the template. For example, a nucleotide analog having a reversible terminator portion may be added to the template such that subsequent extension does not occur until a deblocking agent is delivered to remove the portion. Thus, for examples using reversible termination, the deblocking agent may be delivered to a flow cell, etc. (after detection occurs).

[0212] Washing may occur between the various fluid delivery steps.The SBS cycle may then be repeated n times to extend the template by n nucleotides, thereby detecting a sequence of length n.

[0213] Although SBS has been described in detail, it should be understood that the flow cells 10, 10', 10" described herein may be used for genotyping with other sequencing protocols, or in other chemical and / or biological applications.

[0214] Other flow cell applications

[0215] Although sequencing has been described in detail, it should be understood that the flow cells 10, 10', 10" described herein can be used in other applications that require a positively charged surface. For example, the positively charged polymer hydrogel 14 can be suitable for extracting DNA from a lysate introduced into the flow cell 10, 10', 10". For example, cells can be introduced into the channel 20 or chamber 38, 38', and then a lysis buffer can be introduced. DNA released from the cells can be attracted to the positively charged surface. An external fixative (e.g., oil, air) may or may not be used to further help contain the extracted DNA.

[0216] As another example, the positively charged polymer hydrogel 14 can be used to repel proteins under certain pH conditions, thereby preventing unwanted proteins from binding on the surface. In these examples, the positively charged polymer hydrogel 14 may or may not have an amplification primer 18 attached thereto.

[0217] The flow cells 10, 10', 10" described herein can be used in other applications that require a reversibly charged surface. The reversibly charged surface can be positively charged when the cationic portion 16 is attached and can be negatively charged when the cationic portion 16 is cleaved therefrom. The positively charged surface can help attract DNA, while the negatively charged surface can help elution. The negatively charged surface may also be desirable for pulling positively charged cells (e.g., bacteria) to the flow cell surface.

[0218] In order to further illustrate the present disclosure, examples are given herein. It should be understood that the examples are provided for illustrative purposes and should not be construed as limiting the scope of the present disclosure.

[0219] Non-limiting working examples

[0220] The embodiment flow cell channel and the comparative example flow cell channel were prepared using a glass substrate with two channels. Both channels were silanized and PAZAM was deposited thereon. Then, P5 and P7 primers were grafted to the PAZAM in the channel. A UV curable adhesive was used to bond the cover to the substrate to fluidically isolate the two channels.

[0221] Tris(hydroxypropyl)-phosphine (100 mM THP in 50 mM Tris-HCl buffer (pH 9)) was introduced into the example channel for about 2 minutes at 60° C. Another (comparative) channel was not treated with the mixture.

[0222] The complex used in this example includes a solid support and a ready-to-sequence nucleic acid fragment attached to the solid support via an avidin-biotin linker. The library fragments of the complex are similar to Figure 8B Follow the TRUSEQ TM Platform (Illumina Inc.) protocol PCR-free libraries were prepared in tubes. The libraries were bound to beads by hybridization with P7 primers (which were attached to the beads via biotin). The libraries were stained with Sytox green.

[0223] The complex was introduced into the embodiment and comparative example flow cell channels by flowing a hybridization buffer containing the complex (200 μL in hybridization buffer) through each channel. Inoculation was initiated by releasing the library fragments from the complex. Library release was initiated by heating the flow cell to above the melting temperature of the P7 primer. The fragments were hybridized and the first strand was extended. The solid support and unhybridized fragments were removed with a 0.2M NaOH solution. Bridge amplification was then used for clustering.

[0224] Micrographs of Example and Comparative Example channels were taken after clustering and the original coloring was inverted for clarity. Fig. 9A As shown, the comparative channel not treated with tris(hydroxypropyl)-phosphine had a relatively uniform seeding of the library across the surface. This was evidenced by the darker spots that spread out in the inverted micrographs. Fig. 9B Schematic diagram comparing library release of complexes on a flow cell channel. The diagram depicts the width of the channel, and the scale bar represents the actual size of the field of view of the 2D flow cell inner surface. Fig. 9B As shown in the figure, library fragment transportation and plating are not restricted.

[0225] In contrast, Fig. 10A As shown, the example channel (which was treated with tris(hydroxypropyl)-phosphine) has a concentrated DNA library region. This can be confirmed by concentrated darker spots in the inverted micrograph. Fig. 10B Schematic diagram of library release of complexes on a flow cell channel of an embodiment. The illustration depicts the width of the channel, and the scale bar represents the actual size of the field of view of the inner surface of the 2D flow cell. Fig. 10B As shown, library fragment transport and seeding are limited because negatively charged library fragments are attracted to the positively charged flow cell surface. These results suggest that the tris(hydroxypropyl)phosphine-treated surface is positively charged and therefore is able to attract DNA library fragments as they are released from the complex.

[0226] Additional Notes

[0227] In addition, it should be understood that the ranges provided herein include the specified range and any value or sub-range within the specified range, as if they were explicitly listed. For example, a range expressed by about 2 mm to about 300 mm should be interpreted as including not only the explicitly listed limit values ​​of about 2 mm to about 300 mm, but also single values ​​such as about 15 mm, 22.5 mm, 245 mm, etc., and sub-ranges such as about 20 mm to about 225 mm, etc.

[0228] It should be understood that all combinations of the foregoing concepts and additional concepts discussed in more detail below (assuming such concepts are not mutually inconsistent) are contemplated as being part of the inventive subject matter disclosed herein. Specifically, all combinations of the claimed subject matter appearing at the end of this disclosure are contemplated as being part of the inventive subject matter disclosed herein. It should also be understood that terms explicitly adopted herein that may also appear in any disclosure incorporated by reference should be given the meaning most consistent with the specific concepts disclosed herein.

[0229] While several examples have been described in detail, it is to be understood that the disclosed examples may be modified. Therefore, the above description should be considered non-limiting.

Claims

1. A circulation pool, include: substrate; a cationic polymer hydrogel on the substrate, the cationic polymer hydrogel comprising cationic moieties that are i) integrated into monomeric units of an initial polymer hydrogel or ii) attached to the monomeric units of the initial polymer hydrogel via linkers; as well as Amplification primers are attached to the cationic polymer hydrogel.

2. The flow cell according to claim 1, in: The monomer unit is N-(5-bromoacetamidopentyl)acrylamide; The cationic moiety is a phosphonium cation; and The phosphonium cation displaces the bromine of the N-(5-bromoacetamidopentyl)acrylamide.

3. The flow cell of claim 2, wherein the phosphonium cation is selected from the group consisting of a tris(hydroxymethyl)phosphonium cation, a tris(hydroxypropyl)phosphonium cation, a tetrakis(hydroxymethyl)phosphonium cation, and a tris(2-carboxyethyl)phosphonium cation.

4. The flow cell according to claim 1, in: i) the monomer unit comprises a terminal azide group, and the linker comprises an alkyne group; or ii) the monomer unit comprises a terminal alkyne group, and the linker comprises an azide group.

5. The flow cell of claim 4, wherein the cationic moiety comprises a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof.

6. The flow cell according to claim 4, in: The monomer unit is N-(5-azidoacetamidopentyl)acrylamide; and The cationic moiety is an N,N,N-trimethylethanolammonium cation.

7. The flow cell of claim 4, wherein the linker further comprises a cleavable disulfide bond, a photodegradable bond, a cleavable phosphodiester bond, or a combination thereof.

8. The flow cell according to claim 1, in: The monomer unit is N-(5-azidoacetamidopentyl)acrylamide; The linker includes a terminal alkyne group and a terminal bromine; and The cationic moiety is a phosphonium cation replacing the terminal bromine.

9. The flow cell of claim 1, wherein the substrate comprises a plurality of recessed portions separated by void regions, and wherein the cationic polymer hydrogel is located within each of the recessed portions.

10. The flow cell of claim 9, wherein the substrate further comprises a plurality of chambers, and wherein a subset of the plurality of recesses are located within a perimeter of each of the plurality of chambers.

11. A method, include: introducing a fluid comprising a positively chargeable moiety into a flow cell, the flow cell comprising: an initial polymer hydrogel having a surface moiety selected from the group consisting of negatively chargeable atoms, azide groups, and alkyne groups; and an amplification primer attached to the initial polymer hydrogel; and The initial polymer hydrogel is incubated in the fluid for a period of time and at a temperature to form a cationic polymer hydrogel including cationic moieties.

12. The method of claim 11, wherein the positively chargeable moieties replace the negatively chargeable atoms of the initial polymer hydrogel.

13. The method according to claim 12, in: The surface portion is the negatively chargeable atoms; The negatively chargeable atom is bromine; and The positively chargeable moiety is selected from the group consisting of tris(hydroxymethyl)phosphine, tris(hydroxypropyl)phosphine, tetrakis(hydroxymethyl)phosphine and tris(2-carboxyethyl)phosphine.

14. The method of claim 12, wherein the fluid further comprises a buffer having a pH in the range of 6 to 12.

15. The method of claim 12, wherein the temperature is in the range of 18°C ​​to 65°C, and the time is in the range of 1.5 minutes to 5 minutes.

16. The method according to claim 11, in: The surface moiety is an azide group or an alkyne group; and The positively chargeable moiety is covalently attached to the surface moiety via a linker.

17. The method according to claim 16, in: The surface moiety is an azide group; The linking group is an alkyne group; and The cationic moiety includes a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof.

18. The method according to claim 16, in: The surface moiety is an alkyne group; The linking group is an azide group; and The cationic moiety includes a protonated amine group, a sulfonium ion, a quaternary ammonium cation, or a combination thereof.

19. The method of claim 16, wherein a compound comprises the positively chargeable moiety attached to the linker, and wherein the compound is propargylcholine bromide.

20. The method of claim 16, wherein the fluid comprises water.

21. The method of claim 16, wherein the temperature is in the range of 18°C ​​to 60°C, and the time is in the range of 30 minutes to 12 hours.

22. The method of claim 16, further comprising adding a catalyst, a ligand, and a reducing agent to the flow cell along with the fluid.

23. A kit, include: A circulation cell, comprising: substrate; an initial polymer hydrogel on the substrate and having a surface portion selected from the group consisting of a negatively chargeable atom, an azide group, and an alkyne group; and an amplification primer attached to the initial polymer hydrogel; and A fluid comprising positively chargeable moieties that will interact or react with the surface moieties to form a cationic polymer hydrogel comprising cationic moieties.